Research News

Evan Dellon, MD, MPH, a professor of medicine in the Division of Gastroenterology & Hepatology and director of the Center for Esophageal Diseases and Swallowing, co-leads effort to approve an allergy drug, dupilumab, for the treatment in adults and adolescents with eosinophilic esophagitis. Eosinophilic esophagitis (EoE) is an allergic condition of the esophagus that is … Read more

A Lone star tick next to forceps Alpha-Gal Syndrome, or AGS, is a recently identified tick-borne disease that triggers an allergy to red meat and other products made from mammals, including cheese, gelatin, and medications like heparin. Since its discovery in 2009, cases in the United States alone have risen from 24 to >40,000 people, … Read more

Approximately 100 leading researchers and clinicians, research staff and trainees gathered recently to discuss innovative ways to advance research in arthritis, allergy, and autoimmune diseases. Additionally, attendees who couldn’t participate in person attended remotely. Of particular interest this year was keynote speaker and John B. Winfield, MD Visiting Scholar, Ali Ellebedy, PhD, Associate Professor of Pathology and … Read more

  Seth Berkowitz, MD, MPH Seth A. Berkowitz, MD, MPH, an associate professor in the Division of General Medicine and Clinical Epidemiology in the Department of Medicine, is one of four UNC faculty members awarded the 2022 Phillip and Ruth Hettleman Prize for Artistic and Scholarly Achievement. The Hettleman Prizes were established in 1986 by … Read more

Dr. John Buse and colleagues complete first study comparing commonly used medications for type 2 diabetes Diabetes affects more than one out of every ten Americans and about one out of every three people in their lifetime. John Buse, MD, PhD Type 2 diabetes occurs when the pancreas does not produce enough insulin — a … Read more

Angela Wahl, PhD Angela Wahl, PhD, an assistant professor in the Division of Infectious Diseases in the Department of Medicine, and a member of the Institute for Global Health & Infectious Diseases (IGHID), has received a $3.2 million R01 award to study the role of microglia in HIV latency and persistence in the brain. Over … Read more

Andreea Waltmann and the late Steve Meshnick. Malaria in pregnancy (MiP) is a major public health problem with substantial risks for mothers and their babies. The combination treatment sulfadoxine-pyrimethamine (SP), given for intermittent preventive therapy of malaria in pregnancy (IPTp), is one of the few existing interventions that improve outcomes for both mother and baby, despite widespread … Read more

Medicine, like any other scientific field, cannot progress forward without the hard work of new, cutting-edge researchers. In the Department of Medicine, three physician scientist trainees are working to improve the lives of patients who have inflammatory bowel disease, cancer, and food allergies. In light of their promising, hard work, all three have received support … Read more

Andrew Moon, MD, MPH Outbreaks of hepatitis A, a highly contagious viral infection involving the liver, have been on the rise since 2016. What initially began as outbreaks in a handful of states has since led to ongoing or recent hepatitis A outbreaks in 33 states across the country. Patients under the care of the … Read more

David Weber, MD, MPH COVID-19, a communicable disease caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), is a relatively new pandemic in the public’s eye, but it is only one of the many infectious diseases that epidemiologists like David J. Weber, MD, MPH, are continually facing. “I was at UNC for the onset of … Read more

Tessa Andermann, MD, MPH Tessa Andermann, MD, MPH, assistant professor in the division of infectious diseases, has received a pilot award from the Center for Gastrointestinal Biology and Disease (CGBD) for the study “Investigating the role of secondary bile acid derivatives in Th17-mediated disease: A pilot study of multiple myeloma and treatment response.” Dr. Andermann … Read more

Ethan Basch, MD People with advanced cancer who communicated their symptoms weekly using an electronic survey had about a one-third better physical function and over a 15% better control of their symptoms compared to those who were evaluated less frequently via in-person clinical visits, according to findings from a multi-state study conducted at 52 community … Read more